Sunshine Biopharma (Sunshine Biopharma) Short-Term Capital Lease Obligation : $0.12 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sunshine Biopharma Short-Term Capital Lease Obligation?

Sunshine Biopharma's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.12 Mil.

Sunshine Biopharma's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 ($0.12 Mil) to Dec. 2023 ($0.12 Mil) but then declined from Dec. 2023 ($0.12 Mil) to Mar. 2024 ($0.12 Mil).

Sunshine Biopharma's annual Short-Term Capital Lease Obligation increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.12 Mil) but then declined from Dec. 2022 ($0.12 Mil) to Dec. 2023 ($0.12 Mil).

Sunshine Biopharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Sunshine Biopharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunshine Biopharma Short-Term Capital Lease Obligation Chart

Sunshine Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.12

Sunshine Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.12	0.12	0.12	0.12	0.12

Sunshine Biopharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Sunshine Biopharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sunshine Biopharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunshine Biopharma (Sunshine Biopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunshine Biopharma Inc (NAS:SBFMW) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SBFM:USA

Address

6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, QC, CAN, H9R 0A5

Website

https://www.sunshinebiopharma.com

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).